Elizabeth Warren and the Folly of Genetic Ancestry Tests
By Alondra Nelson,
The New York Times
| 10. 17. 2018
This week, Senator Elizabeth Warren of Massachusetts announced that geneticists had analyzed her DNA and proved her longstanding claim that she has Native American ancestry. Senator Warren had caved in to months of ridicule by President Trump, who mocked her using a racist term and ultimately refused to believe her “useless” DNA test.
The question is not whether her DNA analysis is accurate. It’s whether it can tell us anything meaningful about identity. The truth is that sets of DNA markers cannot tell us who we really are because genetic data is technical and identity is social. The science in question is a form of chromosome mapping similar to that used in the billion-dollar genetic ancestry testing industry in the United States. That testing draws on incomplete data about human genetic diversity.
In this case, the “reference set” included samples drawn from 37 people “from across the Americas with Native American ancestry.” Nevertheless, this genetic analysis did locate five chromosome segments that strongly suggest indigenous ancestry. In his report, the geneticist Carlos Bustamante of Stanford University cautioned that it did...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...